Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors

Clinical trial NCT02993614 · COMPLETED

Trial details

NCT number: NCT02993614
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus Type 2

Start date: 2017-11-30
Primary completion: 2020-12-17
Enrollment: 99999

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.